Evidence map›Paper›PMID 37311571›Full record

ArticleCancer science2023

BACH1 promotes lung adenocarcinoma cell metastasis through transcriptional activation of ITGA2.

Yingji Chen, Longyu Jin, Yuchao Ma, Yicai Liu, Qianjun Zhu, Yu Huang, Wei Feng

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Proteomic profiling identifies an oncogene ITGA2 and its downstream targets in gastric cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yingji ChenDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.
Longyu JinDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.ORCID https://orcid.org/0000-0003-2032-5569
Yuchao MaDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.
Yicai LiuDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.
Qianjun ZhuDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.
Yu HuangDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.
Wei FengDepartment of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, China.ORCID https://orcid.org/0000-0003-0065-6539
Central South University · CN

Funding

National Natural Science Foundation of China No. 81472774Natural Science Foundation of Hunan Province 2021JJ40919
6 · The paper itself

Abstract

BACH1 plays an important role in promoting cancer. This study aims to further verify the relationship between the expression level of BACH1 in lung adenocarcinoma prognosis, as well as the influence of BACH1 expression on lung adenocarcinoma and the potential mechanism. The expression level of BACH1 in lung adenocarcinoma and its relationship with prognosis was evaluated by lung adenocarcinoma tissue microarray analysis combined with bioinformatics approaches. Gene knockdown and overexpression were used to investigate the functions and molecular mechanisms of BACH1 in lung adenocarcinoma cells. The regulatory downstream pathways and target genes of BACH1 in lung adenocarcinoma cells were explored by bioinformatics and RNA sequencing data analysis, real-time PCR, western blot analysis, and cell immunofluorescence and cell adhesion assays. Chromatin immunoprecipitation and dual-luciferase reporter assays were carried out to verify the target gene binding site. In the present study, BACH1 is abnormally highly expressed in lung adenocarcinoma tissues, and high BACH1 expression is negatively correlated with patient prognosis. BACH1 promotes the migration and invasion of lung adenocarcinoma cells. Mechanistically, BACH1 directly binds to the upstream sequence of the ITGA2 promoter to promote ITGA2 expression, and the BACH1-ITGA2 axis is involved in cytoskeletal regulation in lung adenocarcinoma cells by activating the FAK-RAC1-PAK signaling pathway. Our results indicated that BACH1 positively regulates the expression of ITGA2 through a transcriptional mechanism, thereby activating the FAK-RAC1-PAK signaling pathway to participate in the formation of the cytoskeleton in tumor cells and then promoting the migration and invasion of tumor cells.

Indexed as

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsBasic-Leucine Zipper Transcription FactorsCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansIntegrin alpha2Signal TransductionTranscriptional ActivationBACH1 protein, humanBasic-Leucine Zipper Transcription FactorsIntegrin alpha2ITGA2 protein, humanBACH1cytoskeletonITGA2lung adenocarcinomametastasis

Identifiers

PMID37311571
PMCPMC10475762
OpenAlexW4380538428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.